Skip to main content

Clinical evaluation of TIGR® Matrix at Akademikliniken in Stockholm extended – A regional collaboration with global impact

Press Release   •   Dec 02, 2013 14:55 GMT

As previously reported, Akademikliniken in Stockholm are conducting a clinical evaluation of TIGR® Matrix Surgical Mesh, the world’s first long-term resorbable synthetic surgical mesh, designed and manufactured by Novus Scientific in Uppsala, Sweden. As the collaboration so far has been successful, the parties have agreed to extend the scope of the collaboration.

Akademikliniken was founded in 1991 and has since become one of the world’s leading private plastic surgery clinics. Established in five European countries, Akademikliniken is a pioneer and leading authority in aesthetic and reconstructive plastic surgery. Novus Scientific from Uppsala, Sweden, has developed and markets TIGR® Matrix Surgical Mesh, the world’s first long-term absorbable surgical matrix for reinforcement of soft tissue. As previously reported a clinical evaluation of TIGR® Matrix is being performed, aiming to establish gold standard protocols for the use of TIGR® Matrix in aesthetic breast surgery. As the initial experiences have been positive, the collaboration and evaluation are set to continue until 50 patients are included.

Akademikliniken contributes with competence and provides important clinical feedback in order to further improve patient outcomes globally. “Our initial experience with TIGR Matrix in our practice has been very positive. Assuming that it stays this way, TIGR Matrix will be a most valuable tool for us as well as plastic surgeons world-wide” says Dr Per Hedén of Akademikliniken in Stockholm, Sweden. “At Akademikliniken we always try to stay at the front of clinical and technological development and establish protocols and evidence that are of value to our customers. This collaboration is a testament to that philosophy.”

TIGR® Matrix is a synthetic long-term absorbable surgical matrix used in breast reconstructions and abdominal wall surgery to support and reinforce weakened soft tissue during a regeneration phase. The evaluation at Akademikliniken is performed on patients undergoing surgery for capsular contractures, implant asymmetries and other complications that may follow aesthetic breast surgery. Making use of a synthetic absorbable material for temporary reinforcement increases the likelihood of a successful operation and a pleasing, long-term aesthetic result.

”We are proud to work with Akademikliniken and the professionals involved” says Henrik Hjort, Global Product Manager at Novus Scientific and co-inventor of TIGR® Matrix. “This is a regional collaboration with a global impact – it is of course very exciting.”

Experiences from the clinical evaluation will be made publically available at scientific surgical meetings during 2014.

 

About TIGR® Matrix – find out more: www.tigrmatrix.com

TIGR® Matrix Surgical Mesh is a degradable surgical matrix made from synthetic resorbable polymers intended to support and reinforce tissue for 6-9 months and absorbs completely after 3 years. The product is used for soft tissue reinforcement in general and plastic surgery. TIGR® Matrix is CE marked (2011) and has been cleared for marketing by the US FDA (2010).

 

About Akademikliniken - find out more: www.ak.se

Akademikliniken was founded in Stockholm in 1991 by Drs Per Hedén and Jan Jernbeck. Akademikliniken is one of the world’s leading private clinics for aesthetic and reconstructive plastic surgery. The business covers a broad spectrum of different plastic surgery procedures and is the only private clinic in Scandinavia that performs advanced microsurgical procedures. In 2010, Akademikliniken performed approximately 5,000 procedures under general anesthesia and 20,000 other treatments. 10 % of procedures consist of reconstructive plastic surgery carried out for national and international health care providers. Typical reconstructive procedures include breast reconstruction after cancer, abdominplasties after weight-loss surgery and microsurgical treatment of facial paralysis.

About Novus Scientific

Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices. The company’s roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered in San Diego  from where it distributes TIGR® Matrix Surgical Mesh throughout the United States.

TIGR® is a registered trademark of Novus Scientific Pte. Ltd

Attached Files

PDF document